Skip to content

Cabot stock

CBTNYSE

Cabot Corp., Basic MaterialsISIN US1270551013

$72.17▼ $0.06 (−0.1%)Closing price of 12 Nov 2026

61Score 61 out of 100, Neutral

Turn on early warning

Price and trend

46 / 100

Price history

+17% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 9.3% below it.

Trend change

Since October 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 45).

Distance to the high

The price is 23% below its 52-week high. Largest decline in 20 years: 84% (April 2007 to March 2009).

Chart figures for advanced users
SMA 50$76.02
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$79.58
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)45
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$58.71
The lowest closing price of the last twelve months.
Resistance$93.40
The highest closing price of the last twelve months.
Market cap
$3.71B
Div. yield
2.55%
12 months
17.6
Fair value
$118.66

Snapshot

Computed from the data by fixed rules, no AI

  • Cabot Corp. belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $3.71B, is number 72 of 108 companies in its industry on MEQIRI.
  • In fiscal 2026 it reported revenue of $3.74B (up 0.8% year on year) and earnings of $213M (down 35.6%).
  • For fiscal 2027, analysts expect on average revenue of $3.83B (up 2.3%) and adjusted earnings per share of $6.75 (up 5.1%).
Show more
  • MEQIRI Score 61 out of 100 (Neutral): rank 189 of 467 in Basic Materials, median 58.
  • The P/E is 17.6 (Chemicals (Specialty) median 24.4, own median of recent years 15.4).
  • Our model puts fair value at $118.66, with the price 39% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for 29 years.Capital allocation 73
  • Below fair valuePrice 39% below the fair value of $118.66.Valuation 81
  • Share buybacksShare count down 9% since 2021.Capital allocation 73

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

61/ 100
MEQIRI Score
Neutral

Its standout strengths are valuation and fundamentals, while growth and technical analysis hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 60 to 61.

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency80% of years
Cash conversion (free cash flow to earnings, fiscal 2026)100%
ROIC (12 months)10.7%
Positive free cash flow90% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • cyclical sector (energy or materials), as a group, crashed more often in the backtest

What lowers it

  • calm price action

Valuation

Valuation signal

Significantly undervalued
Price
$72.23
Fair value
$118.66
Gap to fair value
−39%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $91.28 and expensive above $169.52 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $137.39 (cash-flow model) and $99.93 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $107.41, at 7.8% it would be $135.53.

Valuation metrics

1.97
6.8
Fair value (model)
$118.66
Earnings part $99.93 (earnings per share $4.10 × 24.4)

Half from the cash-flow model, half from earnings times the industry P/E (24.4).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In fiscal 2026, revenue rose 0.8% on the prior year. Revenue has stayed largely stable since 2007.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2026: gross 22%, operating 13%, net 6%.

Debt & balance sheet

latest quarter
0.71
6.4x
2.16
Cash & equivalents
$254M

Moderate debt, and interest is adequately covered.

Earnings

Next earnings
2 Feb 2027in 82 days
Last reported
2 Nov 2026EPS reported $1.61 (expected $1.55)above expectations

Analyst estimates

Fiscal 20274 analysts
Earnings per share
$6.75−3.4%
Revenue
$3.83B+0.7%
Fiscal 20284 analysts
Earnings per share
$7.54−0.7%
Revenue
$3.97B+0.8%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −5.6%

Battery materials EBITDA of about $40 million reaffirmed and capital spending narrowed to $200 to $215 million, with seasonally lower volumes and normalized gross profit per ton expected in the fourth quarter.

Supporting passage from the call, verbatim
“As we continue to carefully manage capital deployment and align spending with project timing, we are narrowing our expected fiscal 2026 capital expenditure range to $200 million to $215 million, reducing the high end of the range by $15 million.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 4 Aug 2026 (fiscal Q3 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. One insider sold, $19.65M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Keohane Sean DSale

    28 Aug 2026, President and CEO

    Shares
    134,895
    Price
    $85.00
    Value
    $11.47M
  • Keohane Sean DSale

    24 Aug 2026, President and CEO

    Shares
    2,779
    Price
    $85.50
    Value
    $237,605
  • Keohane Sean DSale

    7 Aug 2026, President and CEO

    Shares
    91,923
    Price
    $86.41
    Value
    $7.94M

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Cabot

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

467 rated companies in Basic Materials

Rank 189 of 467
189/ 467
This company
61
Sector median
58

Categories against the sector median

ProfitabilityMedian of 467 companies53 (median 49)4 above the median
GrowthMedian of 467 companies47 (median 54)7 below the median
FundamentalsMedian of 467 companies73 (median 65)8 above the median
ValuationMedian of 426 companies with a value81 (median 69)12 above the median
StabilityMedian of 467 companies72 (median 67)5 above the median
Capital allocationMedian of 467 companies73 (median 52)21 above the median
Technical analysisMedian of 467 companies46 (median 54)8 below the median
MomentumMedian of 467 companies52 (median 51)1 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Chemicals (Specialty)

The next larger and next smaller companies by market value

All 108 Chemicals (Specialty) stocks

ETFs that hold Cabot

Held by 15 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 30 Sep 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 7 Aug 2026)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy